Education
About Us
Working with TipRanks
Follow Us
Life Science Reit Plc (GB:LABS)
LSE:LABS
Total Valuation
Life Science Reit Plc has a market cap or net worth of £144.20M. The enterprise value is 144.93M.
Market Cap£144.20M
Enterprise Value144.93M
Share Statistics
Life Science Reit Plc has 350,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding350,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Life Science Reit Plc’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -175.92%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-175.92%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee-10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover-0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Life Science Reit Plc is -9.52. Life Science Reit Plc’s PEG ratio is -0.17.
PE Ratio-9.52
PS Ratio0.00
PB Ratio0.57
Price to Fair Value0.51
Price to FCF-50.61
Price to Operating Cash Flow9.23
PEG Ratio-0.17
Income Statement
In the last 12 months, Life Science Reit Plc had revenue of -5.63M and earned -13.98M in profits. Earnings per share was -0.04.
Revenue-5.63M
Gross Profit-5.63M
Operating Income-13.98M
Pretax Income-13.98M
Net Income-13.98M
EBITDA9.78M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was 16.31M and capital expenditures -19.28M, giving a free cash flow of -2.97M billion.
Operating Cash Flow16.31M
Free Cash Flow-2.97M
Free Cash Flow per Share>-0.01
Dividends & Yields
Life Science Reit Plc pays an annual dividend of 1p, resulting in a dividend yield of 4.85%
Dividend Per Share1p
Dividend Yield4.85%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change28.12%
50-Day Moving Average42.75
200-Day Moving Average38.80
Relative Strength Index (RSI)44.08
Average Volume (3m)480.79K
Important Dates
Life Science Reit Plc upcoming earnings date is Sep 18, 2025, TBA Not Confirmed.
Last Earnings DateApr 16, 2025
Next Earnings DateSep 18, 2025
Ex-Dividend DateOct 03, 2024
Financial Position
Life Science Reit Plc as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA-0.57
Interest Coverage Ratio-1.52
Taxes
In the past 12 months, Life Science Reit Plc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Life Science Reit Plc EV to EBITDA ratio is 13.03, with an EV/FCF ratio of -20.04.
EV to Sales-22.64
EV to EBITDA13.03
EV to Free Cash Flow-20.04
EV to Operating Cash Flow9.86
Balance Sheet
Life Science Reit Plc has £5.57M in cash and marketable securities with £0.00 in debt, giving a net cash position of -£5.57M billion.
Cash & Marketable Securities£5.57M
Total Debt£0.00
Net Cash-£5.57M
Net Cash Per Share-£0.02
Tangible Book Value Per Share£0.75
Margins
Gross margin is 35.64%, with operating margin of 248.35%, and net profit margin of 248.35%.
Gross Margin35.64%
Operating Margin248.35%
Pretax Margin248.35%
Net Profit Margin248.35%
EBITDA Margin-173.79%
EBIT Margin0.00%
Analyst Forecast
The average price target for Life Science Reit Plc is £37.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£37.00
Price Target Upside-11.06% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast1.84%
EPS Growth Forecast35.65%